BCA
STIM icon

Berman Capital Advisors’s Neuronetics STIM Stock Holding History

Berman Capital Advisors’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$7K Hold
1,173
– – ﹤0.01% 1337
2021
Q2 		$18K Hold
1,173
– – ﹤0.01% 954
2021
Q1 		$14K Hold
1,173
– – ﹤0.01% 928
2020
Q4 		$13K Hold
1,173
– – ﹤0.01% 830
2020
Q3 		$5K Hold
1,173
– – ﹤0.01% 1062
2020
Q2 		$2K Buy
+1,173
New +$2.41K ﹤0.01% 1320

Other funds holding STIM

CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

Berman Capital Advisors's STIM Position: Q3 2021 in Review

Berman Capital Advisors held its Neuronetics (STIM) position steady in Q3 2021 at 1,173 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1337.

Berman Capital Advisors first reported a position in STIM in Q2 2020 and has held it in 6 quarters since. The position peaked at $18K in Q2 2021. 97 funds tracked by Wall St. Rank hold STIM as of Q3 2021.

  • Berman Capital Advisors held 1,173 shares of Neuronetics worth $7K as of Q3 2021.
  • Berman Capital Advisors left its Neuronetics share count unchanged in Q3 2021.
  • Neuronetics made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1337 holding.
  • Berman Capital Advisors first reported a position in Neuronetics in Q2 2020 and has held it in 6 quarters since.
  • Berman Capital Advisors's Neuronetics position peaked at $18K in Q2 2021.
  • 97 funds tracked by Wall St. Rank held Neuronetics as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.